TrialDrug design, development and therapy2015

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.

YoonJung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.